Parameswaran Venugopal to Patient Selection
This is a "connection" page, showing publications Parameswaran Venugopal has written about Patient Selection.
Connection Strength
0.014
-
The combination of fludarabine, cyclophosphamide, and granulocyte-macrophage colony-stimulating factor in the treatment of patients with relapsed chronic lymphocytic leukemia and low-grade Non-Hodgkin's lymphoma. Clin Lymphoma. 2005 Jun; 6(1):26-30.
Score: 0.014